KEGG   DRUG: Pneumococcal 13-valent conjugate vaccine
Entry
D10455                      Drug                                   
Name
Pneumococcal 13-valent conjugate vaccine;
Prevnar 13 (TN);
Prevenar 13 (TN)
Product
Remark
Therapeutic category: 6311
ATC code: J07AL02
Product: D10455<JP/US>
Efficacy
Active immunization (pneumococcal)
  Disease
Prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F [DS:H01321]
Comment
Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 J ANTIINFECTIVES FOR SYSTEMIC USE
  J07 VACCINES
   J07A BACTERIAL VACCINES
    J07AL Pneumococcal vaccines
     J07AL02 Pneumococcus, purified polysaccharides antigen conjugated
      D10455  Pneumococcal 13-valent conjugate vaccine <JP/US>
USP drug classification [BR:br08302]
 Immunological Agents
  Vaccines
   Pneumococcal
    Pneumococcal Conjugate Vaccine, 13 Valent
     D10455  Pneumococcal 13-valent conjugate vaccine
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   631  Vaccines
    6311  Bacterial vaccines
     D10455  Pneumococcal 13-valent conjugate vaccine
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D10455
New drug approvals in Japan [br08318.html]
 Drugs with new active ingredients
  D10455
Other DBs
PubChem: 172232548

» Japanese version   » Back

DBGET integrated database retrieval system